Multimedia |Unicycive Therapeutics
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027
October 22, 2026 · 9:00 AM
- PublishedOctober 22, 2026 · 9:00 AM
- IndustryMultimedia
- LanguageEN
Published by JCN Newswire. Read the original announcement for the full release.
Read the full announcement →